Regeneron Pharmaceuticals · Total Non-Current Liabilities

Latest reported$4.93Bperiod endingDec 31, 2025

REGN FY Total Non-Current Liabilities ($11.40M → $4.93B)

Annual total non-current liabilities

High-resolution chart · PNG

REGN total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	4,933,400,000
Dec 31, 2024	4,461,500,000
Dec 31, 2023	3,683,700,000
Dec 31, 2022	3,409,200,000
Dec 31, 2021	2,733,500,000
Dec 31, 2020	3,440,600,000
Dec 31, 2019	1,618,900,000
Dec 31, 2018	1,534,400,000
Dec 31, 2017	1,484,700,000
Dec 31, 2016	1,282,726,000
Dec 31, 2015	1,143,133,000
Dec 31, 2014	632,761,000
Dec 31, 2013	700,102,000
Dec 31, 2012	671,555,000
Dec 31, 2011	689,580,000
Dec 31, 2010	452,561,000
Dec 31, 2009	250,865,000
Dec 31, 2008	219,034,000
Dec 31, 2007	192,327,000
Dec 31, 2006	323,452,000
Dec 31, 2005	269,142,000
Dec 31, 2004	256,426,000
Dec 31, 2003	268,989,000
Dec 31, 2002	205,475,000
Dec 31, 2001	207,020,000
Dec 31, 2000	12,358,000
Dec 31, 1999	14,200,000
Dec 31, 1998	16,300,000
Dec 31, 1997	18,800,000
Dec 31, 1996	18,700,000
Dec 31, 1995	13,000,000
Dec 31, 1994	9,200,000
Dec 31, 1993	6,100,000
Dec 31, 1992	6,100,000
Dec 31, 1991	4,500,000
Dec 31, 1990	11,400,000